SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

CrowdStrike Holdings, Inc. provides cybersecurity products and services to stop breaches. It offers cloud-delivered protection across endpoints, cloud workloads, identity and data, and threat intelligence, managed security services, IT operations management, threat hunting, Zero Trust identity protection, and log management. CrowdStrike serves customers worldwide. The company was founded by George P. Kurtz, Gregg Marston, and Dmitri Alperovitch on November 7, 2011 and is headquartered in Austin, TX.

Crowdstrike Holdings Inc - Ordinary Shares - Class A

Crowdstrike Holdings Inc

CrowdStrike is drawing attention after a cybersecurity-sector rally tied to headlines about AI-discovered vulnerabilities and a critical PHP flaw, which traders say could heighten demand for security products. Some see the move as evidence of strong sector momentum, while others question whether the rally is justified given CRWDs lofty valuation.

Whirlpool Corp. engages in the manufacturing and marketing of home appliances. Its products include home laundry appliances, refrigerators and freezers, cooking appliances, home dishwashers, and room air-conditioning equipment, mixers, and portable household appliances. The firm's brands include Whirlpool, KitchenAid, Maytag, Consul, Brastemp, Amana, Bauknecht, JennAir, and Indesit. It operates through the following geographical segments: Major Domestic Appliances (MDA) North America, Major Domestic Appliances (MDA) Latin America, Small Domestic Appliances (SDA) Global, and Others. The company was founded by Emory Upton, Fred Upton, and Louis C. Upton on November 11, 1911 and is headquartered in Benton Harbor, MI.

Whirlpool Corp.

Whirlpools weak Q1 results, sharply reduced 2026 outlook, and suspended dividend to prioritize debt reduction have driven heavy selling; management attributed the slump to recession-level appliance demand and the Iran war. Traders are debating whether the decline reflects a temporary demand shock or deeper problems with the companys debt, execution, and management, while some see the selloff as a contrarian buying opportunity.

Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.

Revolution Medicines Inc

ESMO updates on RASONQUE and RAS-targeted combinations are driving discussion, including reported survival benefits across patient subgroups and promising pancreatic-cancer data from Tangos combination with daraxonrasib. Traders are debating whether delays among rival programs could extend Revolution Medicines lead, while weighing the competitive landscape and how the clinical findings translate into durable benefit.

Seagate Technology Holdings Plc operates as holding company that is engaged in the development, production, and distribution of data storage products and electronic data storage solutions. Its products include hard disk drives, solid state hybrid drives, solid state drives, peripheral component interconnect express cards, serial advanced technology attachment controllers, storage subsystems and computing solutions. The firm offers its products under the Backup Plus and Expansion product lines, and Maxtor and LaCie brands. The company was founded in 1978 and is headquartered in Fremont, CA.

Seagate Technology Holdings Plc

Toshibas plan to expand hard-drive capacity has raised fears that added competition could weaken Seagates pricing power, prompting sharp swings in STX alongside Western Digital. Traders are divided: some see a lasting threat to the storage-scarcity thesis, while others view the selloff as an overreaction given the long ramp-up and strong AI data-center demand.

ARK ETF Trust - ARK Innovation ETF

ARK Innovation ETF

ARKK is drawing attention for a tentative rebound and attempts to break out of a prolonged, volatile base, with bullish traders pointing to improving momentum and renewed interest in growth stocks. Others remain skeptical, citing the funds past underperformance and Cathie Woods portfolio decisions.

Ethereum is a global, open-source platform for decentralized applications. In other words, it is a decentralized blockchain platform that enables developers to build and deploy smart contracts and applications without central authority control. Unlike Bitcoin, which primarily functions as digital currency, Ethereum operates as a programmable global computer where developers can create any type of decentralized service.   The platform hosts over $14 billion in DeFi applications with hundreds of thousands of active users across financial protocols, NFT marketplaces, and gaming platforms. Its transition to Proof of Stake in September 2022 reduced energy consumption by over 99%, addressing environmental concerns while strengthening network security.  The network operates through thousands of independent validator nodes that process transactions and execute smart contracts on the Ethereum Virtual Machine. Smart contracts are self-executing programs written in Solidity that automatically carry out agreements when conditions are met, eliminating intermediaries like banks or brokers.   Validators stake ETH as collateral to propose and validate blocks, earning rewards for honest participation while facing penalties for malicious behavior. The EIP-1559 upgrade introduced a dynamic base fee mechanism that burns ETH with each transaction, creating deflationary pressure during high network activity when more ETH is burned than issued to validators.  Vitalik Buterin proposed Ethereum in 2013, but seven co-founders helped build it, including Gavin Wood who created Solidity and the EVM technical specification, and Joseph Lubin who founded ConsenSys. The project launched in July 2015 after raising over $18 million through crowdfunding, quickly becoming the largest blockchain developer community. Major milestones include the 2020 Beacon Chain launch, the 2021 London hard fork implementing fee burning, and the 2022 Merge to Proof of Stake.   Ether (ETH) serves multiple functions: paying transaction fees (gas), staking to secure the network and earn 3-5% annual yields, serving as collateral in DeFi protocols, and purchasing NFTs and digital assets. The asset is increasingly adopted by traditional institutions, with publicly traded companies adding ETH to corporate treasuries to generate staking yields while maintaining blockchain exposure, and in 2024, the SEC approved spot Ethereum ETFs, allowing traditional investors to gain exposure through conventional brokerage accounts.  Ethereum's roadmap focuses on dramatically increasing transaction capacity to over 100,000 per second, reducing confirmation times, and enhancing decentralization while maintaining security against future threats like quantum computing.

Ethereum

Ethereum is drawing attention amid a volatile crypto-market pullback, with traders focused on whether it can hold technical support after selloffs and leveraged-position liquidations. Sentiment is split between calls for further downside and dip buyers anticipating a reversal or short squeeze.

Vanguard Index Funds - Vanguard S&P 500 ETF

Vanguard S&P 500 ETF

VOO is drawing attention amid a broader market pullback, with traders debating whether weakness tied to inflation, elevated yields and geopolitical oil risks could deepen or prove temporary. Bearish crash warnings contrast with dip-buying and long-term investors who view index declines as accumulation opportunities.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics early Phase 1 azer-cel results in progressive MS are drawing attention, with traders highlighting encouraging safety findings and disability scores that were stable or improved in most evaluable patients. Reaction is bullish about the potential to add a pipeline asset beyond BRIUMVI, but some note the small, preliminary study and muted share response, while looking to BRIUMVI sales and upcoming subcutaneous data for further validation.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhoods upcoming Q3 earnings report is the dominant focus, with traders debating whether event-contract revenue can offset weaker crypto activity and slower growth. Optimism about a strong report competes with concern over the sharp selloff, insider-sale speculation, and sensitivity to crypto and broader market weakness.

JD.com, Inc. is a technology-driven E-commerce company, which engages in the sale of electronics products and general merchandise products, including audio, video products, and books. It operates in the following segments: JD Retail, JD Logistics, and New Businesses. The JD Retail segment offers online retail, online marketplace, and marketing services. The JD Logistics segment includes internal and external logistics businesses. The New Businesses segment is composed of JD Property, Jingxi, overseas businesses and technology initiatives. The company was founded on June 18, 1998, by Qiang Dong Liu and is headquartered in Beijing, China.

JD.com Inc - ADR

JDs earnings have sparked debate after shares sold off despite improving profitability and cash flow: bulls view the reaction as excessive and cite the companys cash, buybacks and low valuation, while bears focus on declining revenue and weak Chinese consumer demand. The discussion also reflects persistent caution toward Chinese equities and uncertainty over whether JD can turn better margins into renewed growth.

statis crypto Watchlist

Bitcoin

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

3 Reasons Royalty Pharma Is a Dividend Stock You Never Have to Sell

Key PointsRoyalty Pharma buys drug royalties...

Why Royalty Pharma (RPRX) is Poised to Beat Earnings Estimates Again

Royalty Pharma (RPRX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Royalty Pharma Owns a Piece of 16 Blockbuster Drugs -- Is the Stock a Buy?

Key PointsRoyalty Pharma offers exposure to a diversified portfolio of promising drug products and candidates...

If You Invested $100 In Royalty Pharma Stock 10 Years Ago, You Would Have This Much Today

Royalty Pharma (NASDAQ:RPRX) has outperformed the market over the past 10 years by 26.07% on an annualized basis producing an average annual return of 39.61%. Currently, Royalty Pharma has a market capitalization ofread more...

Want Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings

Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.

Is Buying Royalty Pharma Stock a Safer Way to Bet on Revolution Medicines?

Key PointsRevolution Medicines has just received good news around a drug meant to treat pancreatic cancer...

Is Amarin (AMRN) Stock Outpacing Its Medical Peers This Year?

Here is how Amarin (AMRN) and Royalty Pharma (RPRX) have performed compared to their sector so far this year.

If You Invested $1000 In Royalty Pharma Stock 15 Years Ago, You Would Have This Much Today

Royalty Pharma (NASDAQ:RPRX) has outperformed the market over the past 15 years by 4.89% on an annualized basis producing an average annual return of 18.08%. Currently, Royalty Pharma has a market capitalization ofread more...

Novartis Stock Drops as Trial Failures Ripple Across Biotech Partners

Novartis stock falls following Phase 3 clinical trial failures for del-desiran and pelacarsen, impacting Ionis and Royalty Pharma shares.read more...

Watch These 2 Energy Stocks — S&P 500 Addition Could Come Before Quarter's End

Equity

Bloom Energy and Cheniere Energy are two of the most likely inclusions in the benchmark index, according to Stephens analyst Melissa Roberts. 

Royalty Pharma Plc engages in the provision of drug development services. It operates as a funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals and not-for-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio includes royalties, including AbbVie and J&J’s Imbruvica, Astellas and Pfizer’s Xtandi, Biogen’s Tysabri, Gilead’s HIV franchise, Merck’s Januvia, Novartis’ Promacta, Vertex’s Kalydeco, Orkambi, Symdeko and Trikafta, and five development-stage product candidates. The company was founded by Pablo Gerardo Legorreta and Rory B. Riggs in 1996 and is headquartered in New York, NY.

Royalty Pharma plc - Ordinary Shares - Class A

Bearish Sentiment

<ul class="summary-bullets"><li>If they make the cut, the two companies will be the first energy inclusions in the index since 2022.&nbsp;</li><li>Bloom and Cheniere are the largest companies by market value that are eligible for inclusion in the index, with market values of about $60 billion, well above the current minimum requirement of $22.7 billion.</li><li>Apart from BE and LNG, Roberts has reportedly named Astera Labs and Everpure among the top candidates for admission to the index.</li></ul><p>The S&amp;P 500 rebalancing for the third quarter is due at the end of the month, with announcements expected on Friday. As per market participants and investors, two energy companies are likely to make the list.</p><p><a href="https://stocktwits.com/symbol/BE">Bloom Energy Corp. (BE)</a> and&nbsp;<a href="https://stocktwits.com/symbol/LNG">Cheniere Energy Inc. (LNG)</a> are two of the most likely inclusions in the benchmark index, according to Stephens analyst Melissa Roberts, a&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.barrons.com/articles/sp-500-index-additions-bloom-energy-9e4bf0dc">report</a> from Barron’s said.</p><p>If they make the cut, the two companies will be the first energy inclusions in the index since 2022.&nbsp;</p><h2 class="st-heading-2">Why Are BE, LNG Likely To Be Included In The S&amp;P 500 In Q3?</h2><p>The energy sector has boomed in recent months due to the ongoing energy supply crunch amid the Iran war.&nbsp;</p><p>In a note to clients, Roberts said she expects two or three changes in the index to be announced along with the rebalancing.</p><p>Bloom and Cheniere are the largest companies by market value that are eligible for inclusion in the index, with market values of about $60 billion, well above the current minimum requirement of $22.7 billion.</p><p>As of Thursday’s close, Bloom Energy has a market capitalization of $69.25 billion, as per data from Robinhood. Cheniere has a market capitalization of $60.05 billion.</p><p>According to Roberts, Cheniere has been eligible for some time and could finally be added this quarter, given the strength in the energy sector this year.</p><h2 class="st-heading-2">What Is The Eligibility Criteria To Be Included In The S&amp;P 500 Index?</h2><p>To qualify for inclusion in the S&amp;P 500, a company must be based in the U.S., have a market capitalization of at least $22.7 billion, have positive GAAP earnings in the latest quarter and cumulatively over the past four quarters, and have at least 10% of its shares available to the public.&nbsp;</p><p>It must also meet minimum liquidity and trading-volume requirements, have been publicly traded for at least 12 months, issue common stock, and meet S&amp;P’s requirements on multiple share classes.</p><h2 class="st-heading-2">What’s The Advantage Of S&amp;P 500 Inclusion?</h2><p>Companies added to the S&amp;P 500 command prestige and often see their stock price rise after the announcement.&nbsp;</p><p>For instance,&nbsp;<a href="https://stocktwits.com/symbol/MRVL">Marvell Technology (MRVL)</a>, which was included in the index on June 22, saw its stock jump about 9% immediately after the announcement.</p><p>The companies also benefit from index funds buying as part of requirements. As per Barron’s, an estimated 30% or more of the S&amp;P 500 is held by index funds.</p><h2 class="st-heading-2">Which Other Companies Are Likely To Make It To The S&amp;P 500?</h2><p>Apart from BE and LNG, Roberts has reportedly named&nbsp;<a href="https://stocktwits.com/symbol/ALAB">Astera Labs Inc. (ALAB)</a> and&nbsp;<a href="https://stocktwits.com/symbol/P">Everpure Inc. (P)</a> as being among the top candidates for admission into the index.</p><p>Other possible companies that can make the cut include are&nbsp;<a href="https://stocktwits.com/symbol/CRDO">Credo Technology Group Holdings Ltd. (CRDO)</a>,&nbsp;<a href="https://stocktwits.com/symbol/HEI">Heico Corp. (HEI)</a>,&nbsp;<a href="https://stocktwits.com/symbol/RKT">Rocket Companies Inc. (RKT)</a>, and&nbsp;<a href="https://stocktwits.com/symbol/RPRX">Royalty Pharma Inc. (RPRX)</a>, Roberts reportedly noted.</p><h2 class="st-heading-2">BE, LNG Stocks: Retail Stance</h2><p>On Stocktwits, retail sentiment around BE stock improved from ‘neutral’ to ‘bullish’ over 24 hours amid ‘high’ message volumes.&nbsp;</p><p>One user&nbsp;<a href="https://stocktwits.com/lowwhigh/message/663384795">said</a>, “$BE uhhhhh i think they might get included in s&amp;p,apparently&nbsp; they sre the top runner. 44% chnace of inclusion! WOW!!”</p><p>Retail sentiment around LNG stock improved from ‘bullish’ to ‘extremely bullish’ at the time of writing amid ‘normal’ message volumes.&nbsp;</p><p>One user&nbsp;<a href="https://stocktwits.com/OPEN_LIFE/message/663537812">said</a>, “SP500 rebalancing tomorrow and they are going to add $LNG.”</p><p>BE stock is up more than 138% so far in 2026, while LNG stock has gained about 47% in the same time.&nbsp;</p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com.</i></p>

In this photo illustration, a S&P 500 stock market index words are seen on a smartphone screen and a graphic in the background. (Photo Illustration by Pavlo Gonchar/SOPA Images/LightRocket via Getty Images)

Bloom Energy and Cheniere Energy are two of the most likely inclusions in the benchmark index, according to Stephens analyst Melissa Roberts.

Astera Labs Inc

Bloom Energy Corp - Ordinary Shares - Class A

Credo Technology Group Holding Ltd

Heico Corp.

Cheniere Energy Inc.

Everpure Inc

Rocket Companies Inc

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$63.86
Prev Close	$63.75
Open	$63.50
Dividend Yield	2.28%
50-Day Moving Average	$59.72
Beta	0.27
Avg. Volume	3.28M
PE Ratio	34.00

52-Week High	$64.38
52-Week Low	$35.92
Market Capitalization	$36.81B
EPS (Annual)	$1.78
Price to Book	4.17
Revenue Per Employee	$23.78M

Feed

News

Sentiment

Earnings

Fundamentals

Info

RPRX Fundamentals